A Phase 2 interventional study of Sage 2% Chlorhexidine Gluconate Cloth Patient Preoperative Skin Preparation in Clostridium Difficile, sponsored by Jared Brooks. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-07-11.
Sponsored by Jared Brooks · Phase 2, Interventional, and Prevention
Clostridium difficile (C. diff.) infections, whether nosocomial or community borne, may present with profound diarrhea, especially in those patients receiving antibiotics. Based on a preliminary review of hospital data, the investigators have found that these symptomatic c. diff infections occur with a relatively high incidence at Delnor Hospital. Notwithstanding their high mortality, one recent study attributes a near quadrupling of hospitalization costs to c. diff infections. Chlorhexidine baths have been shown in multiple randomized trials to help reduce the incidence of highly virulent pathogens and hospital acquired infections. Further, several studies show a favorable effect of reducing the incidence of c. diff infections by using Chlorhexidine baths on ICU patients. Far fewer studies, however, have focused on the effects of these baths on general medical/surgical wards. This investigation seeks to study the effect of the daily use of 2% Chlorhexidine gluconate wipes in patients on the general medical/surgical wards who are exposed to antibiotics for a suspected or confirmed infection.
310 studies on the registry are indexed under Clostridium Infections; 50 are open to participants now.
This study's enrollment of 167 is above the median of 65 across 233 interventional studies indexed under Clostridium Infections.
Browse Clostridium Infections studies →This is the only study on the registry with Jared Brooks as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Receive the bathing standard of care.
Receive daily bathing with 2% Chlorhexidine gluconate bathing wipes.
Drug: Sage 2% Chlorhexidine Gluconate Cloth Patient Preoperative Skin Preparation
Daily bathing.
Number of participants with Relative Risk of C-diff infection
Study data will cease to be collected after 300 participants have been enrolled or until 12 months have elapsed. Data will be collected and assessed monthly.
Time frame: up to 12 months
Duration of Hospital stays
Time frame: expected average of six days
This study is completed, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.